Modulation of the binding of basic fibroblast growth factor and heparanase activity by purified λ-carrageenan oligosaccharides

Carbohydrate Polymers

Volumn 125, Issue , 2015, Pages 76-84

  Niu, Ting Ting ^a   Zhang, Dong Sheng ^a   Chen, Hai Min ^a   Yan, Xiao Jun ^a  

^a NINGBO UNIVERSITY   (China)

Author keywords

Basic fibroblast growth factor; Heparanase; Heparin sulfate mimic; Carrageenan oligosaccharides

Indexed keywords

BINDING ENERGY; CELL CULTURE; CELL PROLIFERATION; DISEASES; DISSOCIATION; ENDOTHELIAL CELLS; FIBROBLASTS; MASS SPECTROMETRY; PURIFICATION;

BASIC FIBROBLAST GROWTH FACTOR; BINDING KINETICS; CARRAGEENANS; DEGREE OF POLYMERIZATION; HEPARANASE; HEPARANASE INHIBITORS; HEPARIN SULFATES; TUMOR METASTASIS;

OLIGOSACCHARIDES;

BACTERIAL PROTEIN; BETA GLUCURONIDASE; CARRAGEENAN; FIBROBLAST GROWTH FACTOR; GLYCOSIDASE; HEPARANASE; LAMBDA-CARRAGEENASE, PSEUDOALTEROMONAS; PROTEIN BINDING; SURAMIN;

CELL PROLIFERATION; CHEMISTRY; DRUG EFFECTS; HUMAN; METABOLISM; PHYSIOLOGY; UMBILICAL VEIN ENDOTHELIAL CELL;

BACTERIAL PROTEINS; CARRAGEENAN; CELL PROLIFERATION; FIBROBLAST GROWTH FACTORS; GLUCURONIDASE; GLYCOSIDE HYDROLASES; HUMAN UMBILICAL VEIN ENDOTHELIAL CELLS; HUMANS; PROTEIN BINDING; SURAMIN;

EID: 84925680440     PISSN: 01448617     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.carbpol.2015.02.069     Document Type: Article

References (37)

1. A. Antonopoulos, P. Favetta, W. Helbert, and M. Lafosse Isolation of κ-carrageenan oligosaccharides using ion-pair liquid chromatography-characterisation by electrospray ionisation mass spectrometry in positive-ion mode Carbohydrate Research 339 2004 1301 1309
2. S. Arungundram, K. Al-Mafraji, J. Asong, F.E. Leach III, I.J. Amster, and A. Venot Modular synthesis of heparan sulfate oligosaccharides for structure-activity relationship studies Journal of the American Chemical Society 131 2009 17394 17405
3. V.L. Campo, D.F. Kawano, D.B. Silva Jr., and I. Carvalho Carrageenans: Biological properties, chemical modifications and structural analysis - A review Carbohydrate Polymers 77 2009 167 180
4. B. Casu, A. Naggi, and G. Torri Heparin-derived heparan sulfate mimics to modulate heparan sulfate-protein interaction in inflammation and cancer Matrix Biology 29 2010 442 452
5. H.M. Chen, Y. Gao, and X.J. Yan Carrageenan oligosaccharides inhibit growth-factor binding and heparanase activity Acta Pharmaceutica Sinica 46 2011 280 284
6. H.M. Chen, X.J. Yan, J. Lin, F. Wang, and W.J. Xu Depolymerized products of λ-carrageenan as a potent angiogenesis inhibitor Journal of Agricultural and Food Chemistry 55 2007 6910 6917
7. H.M. Chen, X.J. Yan, F. Wang, W.F. Xu, and L. Zhang Assessment of the oxidative cellular toxicity of a κ-carrageenan oxidative degradation product towards Caco-2 cells Food Research International 43 2010 2390 2401
8. M. Fannon, K.E. Forsten, and M.A. Nugent Potentiation and inhibition of bFGF binding by heparin: A model for regulation of cellular response Biochemistry 39 2000 1434 1445
9. W. Feng, L. Zhao, and K. Wang Interaction of polysaccharides with interferon-gamma using an improved ELISA approach Carbohydrate Polymers 58 2004 89 94
10. F. Galeotti, and N. Volpi Novel reverse-phase ion pair-high performance liquid chromatography separation of heparin, heparan sulfate and low molecular weight-heparins disaccharides and oligosaccharides Journal of Chromatography A 1284 2013 141 147
11. N.S. Gandhi, and R.L. Mancera Heparin/heparan sulphate-based drugs Drug Discovery Today 15 2010 1058 1069
12. Y. Gao, H.M. Chen, J.L. Xu, D.Y. Chen, and X.J. Yan Analysis of oligo-κ-carrageenan by reversed phase ion-pair ultra performance liquid chromatography coupled with electrospray ionization-time of flight-mass spectrometry Chinese Journal of Analytical Chemistry 37 2009 1590 1595
13. M. Guibet, S. Colin, T. Barbeyron, S. Genicot, B. Kloareg, and G. Michel Degradation of λ-carrageenan by Pseudoalteromonas carrageenovora λ-carrageenase: A new family of glycoside hydrolases unrelated to κ and ι-carrageenases Biochemistry Journal 403 2007 105 114
14. S. Guimond, M. Maccarana, B.B. Olwin, U. Lindahl, and A.C. Rapraeger Activating and inhibitory heparin sequences for FGF-2 (basic FGF). Distinct requirements for FGF-1, FGF-2, and FGF-4 Journal of Biological Chemistry 268 1993 23906 23914
15. R. Hoffman, and D.H. Paper Carrageenans: novel, selective growth factor antagonists with anti-proliferative activity British Journal of Cancer 68 1993 442 443
16. X. Hong, F. Jiang, S.N. Kalkanis, Z.G. Zhang, X.P. Zhang, and X.G. Zheng Increased chemotactic migration and growth in heparanase-overexpressing human U251n glioma cells Journal of Experimental & Clinical Cancer Research 27 2008 1 8
17. K. Ishida, M.K. Wierzba, T. Teruya, S. Simizu, and H. Osada Novel heparan sulfate mimetic compounds as antitumor agents Chemistry & Biology 11 2004 367 377
18. M.H. Ji Carrageenan Seaweed Chemistry 3rd ed. 1997 Science Press Beijing, China 123 124
19. G.L. Jiao, G.L. Yu, J.Z. Zhang, and E. Stephen Chemical structures and bioactivities of sulfated polysaccharides from marine algae Marine Drugs 9 2011 196 223
20. C.W. Käsbauer, D.H. Paper, and G. Franz Sulfated β-(1-4)-galacto-oligosaccharides and their effect on angiogenesis Carbohydrate Research 330 2001 427 430
21. J. Kovensky Sulfated oligosaccharides: New targets for drug development? Current Medicinal Chemistry 16 2009 2338 2344
22. A.Y. Liang, X.M. Zhou, Q.Y. Wang, X. Liu, X.J. Liu, and Y.G. Du Structural features in carrageenan that interact with a heparin-binding hematopoietic growth factor and modulate its biological activity Journal of Chromatography B 843 2006 114 119
23. S. Liekens, D. Leali, J. Neyts, R. Esnouf, M. Rusnati, and P. Dell'Era Modulation of fibroblast growth factor-2 receptor binding, signaling, and mitogenic activity by heparin-mimicking polysulfonated compounds Molecular Pharmacology 56 1999 204 213
24. N. Liu, and S. Zhuang Tissue protective and anti-fibrotic actions of suramin: New uses of an old drug Current Clinical Pharmacology 6 2011 137 142
25. R.P. McGeary, A. Bennett, Q.B. Tran, K.L. Cosgrove, and B.P. Ross Suramin: Clinical uses and structure-activity relationships Mini Reviews in Medicinal Chemistry 8 2008 1384 1394
26. E.A. McKenzie Heparanase: A target for drug discovery in cancer and inflammation British Journal of Pharmacology 151 2007 1 14
27. T. Mosmann Rapid colorimetric assay for cellular growth and survival: Application to proliferation and cytotoxicity assay Journal of Immunological Methods 65 1983 55 63
28. D.H. Paper, H. Vogl, G. Franz, and R. Hoffman Defined carrageenan derivatives as angiogenesis inhibitors Macromolecular Symposia 99 1 1995 219 225
29. M. Presta, D. Leali, H. Stabile, R. Ronca, M. Camozzi, and L. Coco Heparin derivatives as angiogenesis inhibitors Current Pharmaceutical Design 9 2003 553 566
30. A. Raz, G. Levine, and Y. Khomiak Acute local inflammation potentiates tumor growth in mice Cancer Letters 148 2000 115 120
31. J. Sun, D. Wang, R.K. Jain, A. Carie, S. Paquette, and E. Ennis Inhibiting angiogenesis and tumorigenesis by a synthetic molecule that blocks binding of both VEGF and PDGF to their receptors Oncogene 24 2005 4701 4709
32. R. Vinegar, J.F. Truax, and J.L. Selph Quantitative studies of the pathway to acute carrageenan inflammation Federation Proceedings 35 1976 2447 2456
33. I. Vlodavsky, N. Ilan, A. Naggi, and B. Casu Heparanase: structure, biological functions, and inhibition by heparin-derived mimetics of heparan sulfate Current Pharmaceutical Design 13 2007 2057 2073
34. W. Wang, P. Zhang, C. Hao, X.E. Zhang, Z.Q. Cui, and H.S. Guan In vitro inhibitory effect of carrageenan oligosaccharide on influenza A H1N1 virus Antiviral Research 92 2011 237 246
35. B. Yang, G.L. Yu, X. Zhao, G.L. Jiao, S.M. Ren, and W.G. Chai Mechanism of mild acid hydrolysis of galactan polysaccharides with highly ordered disaccharide repeats leading to a complete series of exclusively odd-numbered oligosaccharides FEBS Journal 276 2009 2125 2137
36. F.M. Zhang, Z.Q. Zhang, X.F. Lin, A. Beenken, A.V. Eliseenkova, and M. Mohammadi Compositional analysis of heparin/heparan sulfate interacting with fibroblast growth factor·fibroblast growth factor receptor complexes Biochemistry 48 2009 8379 8386
37. H.J. Zhao, H.Y. Liu, Y. Chen, X.L. Xin, J. Li, and Y.T. Hou Oligomannurarate sulfate, a novel heparanase inhibitor simultaneously targeting basic fibroblast growth factor, combats tumor angiogenesis and metastasis Cancer Research 66 2006 8779 8787